Suppr超能文献

新型干扰素-γ释放试验对三级医疗机构中潜伏性和活动性感染的诊断有益吗?

Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Infections in Tertiary Care Setting?

作者信息

Jung Jaewan, Jhun Byung Woo, Jeong Mijeong, Yoon Sun Joo, Huh Hee Jae, Jung Chul Won, Kim Kihyun, Park Jae Berm, Kim Dae Joong, Huh Wooseong, Jang Hye Ryoun, Kim Young-Ho, Hong Sung Noh, Chung Doo Ryeon, Kang Eun-Suk

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

出版信息

J Clin Med. 2021 Mar 29;10(7):1376. doi: 10.3390/jcm10071376.

Abstract

Interferon-Gamma Release Assays (IGRAs) are widely used in the laboratory diagnosis of (MTB) infections, particularly in the latent form. We compared the performance of a newly developed IGRA, the Standard E TB-Feron ELISA (TBF) with the currently used QuantiFERON-TB Gold Plus assay (QFT-Plus) for the detection of latent tuberculosis infections (LTBIs) in tertiary care settings. We also investigated interferon-gamma (IFN-γ) released by T cell subsets via intracellular cytokine staining (ICS) and flow cytometry. A total of 335 subjects including 40 patients with active tuberculosis (ATB), 75 immunocompromised patients with LTBIs (P-LTBI), 70 health care workers with LTBIs (H-LTBI), and 150 healthy controls (HC) were studied. Overall, 168 subjects (50.1%) and 178 subjects (53.1%) displayed IGRA-positive results in the QFT-Plus and TBF, respectively. The overall concordance rate was 94.0%. The sensitivity and specificity of TBF were 88% and 95%, respectively, while the sensitivity and specificity of QFT-Plus were 90% and 100%, respectively. Twenty discordant results (6.0%) were observed in simultaneously performed QFT-Plus and TBF. Particularly, 13 LTBI subjects previously positive QFT-Plus showed negative results in QFT-Plus performed after enrollment. In TBF, six subjects showed positive results while five were negatively concordant with QFT-plus and two were indeterminate. The overall proportion of IFN-γ releasing CD8+ T lymphocytes was significantly higher in TBF compared to those of QFT-Plus TB1 and TB2 (0.21% vs. 0.01% and 0.02%; -value < 0.05). The recombinant protein antigens in the TBF stimulated TB-specific CD8+ T cells more efficiently. Therefore, TBF would be a useful alternative to current IGRAs such as the QFT-Plus, particularly in tertiary care settings where the immunocompromised patients are subjected to IGRA tests to differentiate MTB infection. Further strategies to analyze the implications of the discrepancies, particularly near the cutoff values between different IGRAs, are needed.

摘要

干扰素-γ释放检测(IGRAs)广泛应用于结核分枝杆菌(MTB)感染的实验室诊断,尤其是潜伏感染形式。我们比较了新开发的IGRA——标准E TB-Feron ELISA(TBF)与目前使用的QuantiFERON-TB Gold Plus检测(QFT-Plus)在三级医疗机构中检测潜伏性结核感染(LTBI)的性能。我们还通过细胞内细胞因子染色(ICS)和流式细胞术研究了T细胞亚群释放的干扰素-γ(IFN-γ)。共研究了335名受试者,包括40例活动性结核病(ATB)患者、75例免疫功能低下的LTBI患者(P-LTBI)、70例医护人员LTBI患者(H-LTBI)和150名健康对照(HC)。总体而言,分别有168名受试者(50.1%)和178名受试者(53.1%)在QFT-Plus和TBF检测中显示IGRA阳性结果。总体一致性率为94.0%。TBF的敏感性和特异性分别为88%和95%,而QFT-Plus的敏感性和特异性分别为90%和100%。在同时进行的QFT-Plus和TBF检测中观察到20个不一致结果(6.0%)。特别是,13名先前QFT-Plus检测呈阳性的LTBI受试者在入组后进行的QFT-Plus检测中显示阴性结果。在TBF检测中,6名受试者呈阳性结果,5名与QFT-Plus检测结果呈阴性一致,2名结果不确定。与QFT-Plus的TB1和TB2相比,TBF检测中IFN-γ释放的CD8+T淋巴细胞总体比例显著更高(0.21%对0.01%和0.02%;P值<0.05)。TBF中的重组蛋白抗原更有效地刺激了结核特异性CD8+T细胞。因此,TBF可能是当前IGRAs(如QFT-Plus)的有用替代方法,特别是在三级医疗机构中,免疫功能低下的患者接受IGRA检测以区分MTB感染。需要进一步分析差异影响的策略,特别是不同IGRAs临界值附近的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a060/8036413/4523ac651f05/jcm-10-01376-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验